Neuropace, Inc. Common Stock NPCE
i
Market dataready · fetched 2026-11-11T13:59:33.131Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-10T21:00:01.416039483Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-11T13:59:32.583360+00:00
Neuropace, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | 10.30 | 280.9% | 27.2% | |||
| 30Δ | 10.96 | 256.8% | 23.0% | |||
| 35Δ | 11.62 | 232.7% | 18.9% | |||
| 40Δ | 14.81 | 222.5% | 25.2% | 12.28 | 208.5% | 14.7% |
| 45Δ | 14.21 | 226.6% | 22.3% | 12.67 | 192.1% | 12.4% |
| 50Δ | 13.61 | 230.6% | 19.5% | 12.92 | 179.4% | 11.1% |
| 55Δ | 13.01 | 234.7% | 16.7% | 13.17 | 166.7% | 9.8% |
| 60Δ | 12.40 | 238.6% | 13.9% | 13.42 | 154.0% | 8.5% |
| 65Δ | 11.76 | 241.6% | 11.8% | 13.67 | 141.3% | 7.2% |
| 70Δ | 11.12 | 244.6% | 9.7% | 13.92 | 128.6% | 5.9% |
| 75Δ | 10.49 | 247.6% | 7.6% | 14.17 | 115.9% | 4.6% |
| 80Δ | 9.66 | 268.7% | 5.9% | 14.42 | 103.2% | 3.3% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.30
- IV
- 280.9%
- B/E move
- 27.2%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 10.96
- IV
- 256.8%
- B/E move
- 23.0%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 11.62
- IV
- 232.7%
- B/E move
- 18.9%
40Δ
- Pseudo strike
- 14.81
- IV
- 222.5%
- B/E move
- 25.2%
- Pseudo strike
- 12.28
- IV
- 208.5%
- B/E move
- 14.7%
45Δ
- Pseudo strike
- 14.21
- IV
- 226.6%
- B/E move
- 22.3%
- Pseudo strike
- 12.67
- IV
- 192.1%
- B/E move
- 12.4%
50Δ
- Pseudo strike
- 13.61
- IV
- 230.6%
- B/E move
- 19.5%
- Pseudo strike
- 12.92
- IV
- 179.4%
- B/E move
- 11.1%
55Δ
- Pseudo strike
- 13.01
- IV
- 234.7%
- B/E move
- 16.7%
- Pseudo strike
- 13.17
- IV
- 166.7%
- B/E move
- 9.8%
60Δ
- Pseudo strike
- 12.40
- IV
- 238.6%
- B/E move
- 13.9%
- Pseudo strike
- 13.42
- IV
- 154.0%
- B/E move
- 8.5%
65Δ
- Pseudo strike
- 11.76
- IV
- 241.6%
- B/E move
- 11.8%
- Pseudo strike
- 13.67
- IV
- 141.3%
- B/E move
- 7.2%
70Δ
- Pseudo strike
- 11.12
- IV
- 244.6%
- B/E move
- 9.7%
- Pseudo strike
- 13.92
- IV
- 128.6%
- B/E move
- 5.9%
75Δ
- Pseudo strike
- 10.49
- IV
- 247.6%
- B/E move
- 7.6%
- Pseudo strike
- 14.17
- IV
- 115.9%
- B/E move
- 4.6%
80Δ
- Pseudo strike
- 9.66
- IV
- 268.7%
- B/E move
- 5.9%
- Pseudo strike
- 14.42
- IV
- 103.2%
- B/E move
- 3.3%
Options history
Table
| Date | IV (%) |
|---|---|
| 80.26% | |
| 85.34% | |
| 93.21% | |
| 86.69% | |
| 91.79% | |
| 85.05% | |
| 91.80% | |
| 94.27% | |
| 92.99% | |
| 92.41% |
Medical Devices
NVCR
NovoCure Limited, an oncology company, is engaged in the development, manufacture and marketing of Optune for the treatment of a variety of solid tumors. The company is…
More →OFIX
Orthofix Medical Inc. is a medical device and biological products company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. The company is…
More →OM
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. The company is headquartered in San Jose, California.
More →OWLT
Owlet Inc. is a leading innovator in infant health technology, dedicated to enhancing the safety and wellness of newborns through its state-of-the-art monitoring solutions. The…
More →PACB
Description unavailable
More →PEN
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company is headquartered in…
More →